Lizzul Paul F. — SEC insider filings

SEC reporting owner CIK 1711462. 25 insider filings on record with FilingPulse; latest filed 2026-11-03.

Transaction summary — filings shown

Covers all 25 filings on record, filed 2021-02-12 to 2026-11-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ANAPTYSBIO, INC (ANAB)Chief Medical Officer20—10 legs · 23,483 sh · $895,16441
First Tracks Biotherapeutics, Inc. (TRAX)Chief Medical Officer5——16

Insider filings — Lizzul Paul F.

FiledFormIssuerReported transactionsSource
2026-11-034First Tracks Biotherapeutics, Inc. (TRAX)Grant/award (A): 42,500 (derivative) @ $0EDGAR
2026-08-184First Tracks Biotherapeutics, Inc. (TRAX)Grant/award (A): 60,492 (derivative) @ $0EDGAR
2026-08-074ANAPTYSBIO, INC (ANAB)Grant/award (A): 16,667 (derivative) @ $0EDGAR
2026-08-054First Tracks Biotherapeutics, Inc. (TRAX)Grant/award (A): 60,492 (derivative) @ $0EDGAR
2026-05-144First Tracks Biotherapeutics, Inc. (TRAX)Grant/award (A): 26,700 (derivative) @ $0 · Grant/award (A): 72,300 (derivative) @ $0EDGAR
2026-04-224First Tracks Biotherapeutics, Inc. (TRAX)Grant/award (A): 83,500 (derivative) @ $0 · Grant/award (A): 45,000 (derivative) @ $0 · Grant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 67,070 (derivative) @ $0 · Grant/award (A): 115,540 (derivative) @ $0 · Grant/award (A): 97,200 (derivative) @ $0 · +5 moreEDGAR
2026-01-094ANAPTYSBIO, INC (ANAB)Option exercise (M): 8,525 · Sale (S): 3,650 @ $44.71 · Option exercise (M): 8,525 (derivative) @ $0EDGAR
2026-01-084ANAPTYSBIO, INC (ANAB)Option exercise (M): 6,145 · Sale (S): 2,235 @ $45.11 · Option exercise (M): 6,145 (derivative) @ $0 · Grant/award (A): 21,400 (derivative) @ $0 · Grant/award (A): 29,000 (derivative) @ $0EDGAR
2026-01-064ANAPTYSBIO, INC (ANAB)Option exercise (M): 10,555 · Sale (S): 4,219 @ $43.26 · Option exercise (M): 10,555 (derivative) @ $0EDGAR
2025-12-234ANAPTYSBIO, INC (ANAB)Option exercise (M): 1,500 @ $18.50 · Sale (S): 1,500 @ $50 · Option exercise (M): 1,500 (derivative) @ $0EDGAR
2025-01-074ANAPTYSBIO, INC (ANAB)Option exercise (M): 10,555 · Tax withholding (F): 4,336 @ $14.60 · Option exercise (M): 6,145 · Tax withholding (F): 2,261 @ $15.30 · Option exercise (M): 10,555 (derivative) @ $0 · Option exercise (M): 6,145 (derivative) @ $0 · +2 moreEDGAR
2024-09-244ANAPTYSBIO, INC (ANAB)Option exercise (M): 1,500 @ $18.50 · Sale (S): 1,500 @ $38.67 · Option exercise (M): 1,500 (derivative) @ $0EDGAR
2024-09-174ANAPTYSBIO, INC (ANAB)Option exercise (M): 6,000 · Sale (S): 2,220 @ $38.93 · Option exercise (M): 6,000 (derivative) @ $0EDGAR
2024-08-164ANAPTYSBIO, INC (ANAB)Option exercise (M): 2,000 @ $18.50 · Sale (S): 2,000 @ $40 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2024-07-244ANAPTYSBIO, INC (ANAB)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2024-07-194ANAPTYSBIO, INC (ANAB)Option exercise (M): 1,500 @ $18.50 · Sale (S): 1,500 @ $35 · Option exercise (M): 1,500 (derivative) @ $0EDGAR
2024-01-094ANAPTYSBIO, INC (ANAB)Option exercise (M): 6,145 @ $0 · Sale (S): 2,554 @ $21.81 · Option exercise (M): 6,145 (derivative) @ $0EDGAR
2024-01-054ANAPTYSBIO, INC (ANAB)Grant/award (A): 115,540 (derivative) @ $0 · Grant/award (A): 42,220 (derivative) @ $0EDGAR
2023-09-184ANAPTYSBIO, INC (ANAB)Option exercise (M): 6,000 · Sale (S): 2,105 @ $19.48 · Option exercise (M): 6,000 (derivative) @ $0EDGAR
2023-01-104ANAPTYSBIO, INC (ANAB)Grant/award (A): 67,070 (derivative) @ $0 · Grant/award (A): 24,580 (derivative) @ $0EDGAR
2022-09-164ANAPTYSBIO, INC (ANAB)Grant/award (A): 12,000 (derivative) @ $0EDGAR
2022-06-274ANAPTYSBIO, INC (ANAB)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2022-02-144ANAPTYSBIO, INC (ANAB)Grant/award (A): 70,000 (derivative) @ $0EDGAR
2021-11-174ANAPTYSBIO, INC (ANAB)Grant/award (A): 964 @ $22.03EDGAR
2021-02-124ANAPTYSBIO, INC (ANAB)Grant/award (A): 45,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-02-12 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1711462 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs